MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress » Spasticity

Meeting: 2022 International Congress

Benefit of multiple incobotulinumtoxinA injections for pain reduction in adult patients with limb spasticity: an analysis of pooled data from phase 2 and 3 studies

J. Wissel, A. Camões-Barbosa2, G. Comes, M. Althaus, A. Scheschonka, D. Simpson (Potsdam, Germany)

Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections

J. Jacinto (Alcabideche, Portugal)

Hereditary spastic paraplegia caused by mutations in SPAST, REEP1, or ATL1: A systematic review

ED. Aksoy, İ. Işık (ankara, Turkey)

Outcome measurement and goal setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin

J. Jacinto, A. Camões Barbosa, S. Carda, D. Hoad, J. Wissel (Alcabideche, Portugal)

Pain and Disability Outcomes in Hemiparetic Patients Naive to Botulinum Toxins With Upper and Lower Limb Spasticity Treated With OnabotulinumtoxinA: Insights From the ASPIRE Study

G. Bavikatte, A. Esquenazi, W. Jost, A. Barichich, E. Duarte, M. Schwartz, T. Musacchio, G. Francisco (Liverpool, United Kingdom)

Pain and Disability Outcomes in Hemiparetic Patients With Post-Stroke Spasticity: Exploratory Analysis of the ASPIRE Study

G. Bavikatte, G. Francisco, W. Jost, A. Barichich, E. Duarte, M. Schwartz, T. Musacchio, A. Esquenazi (Liverpool, United Kingdom)

Pain reduction in adult patients with limb spasticity following a single incobotulinumtoxinA injection: an analysis of pooled data from phase 2 and 3 studies

J. Wissel, A. Camões-Barbosa, G. Comes, M. Althaus, A. Scheschonka, D. Simpson (Potsdam, Germany)

Pooled safety analysis of incobotulinumtoxinA in the treatment of neurological disorders in adults

C. Comella, M. Hast, A. Hanschmann (Chicago, USA)

Real-World Clinical Utilization Differences of onabotulinumtoxinA and abobotulinumtoxinA in Upper Limb Spasticity

M. Nelson, A. Zuzek, M. Schwartz, R. Singh (Irvine, USA)

The efficacy of Botulinum toxin A in reducing muscle spasticity by different volumes of dilution

R. Marvulli, G. Ianieri, G. Mintrone, A. Zonno, L. Rizzo, G. Farì, M. Ranieri, M. Megna (Bari, Italy)

« View all sessions from the 2022 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley